- Home
- DNLI vs ADUS Comparison
DNLI vs ADUS Comparison
Compare DNLI & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ADUS
- Stock Information
- Founded
- DNLI 2013
- ADUS 1979
- Country
- DNLI United States
- ADUS United States
- Employees
- DNLI N/A
- ADUS N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ADUS Medical/Nursing Services
- Sector
- DNLI Health Care
- ADUS Health Care
- Exchange
- DNLI Nasdaq
- ADUS Nasdaq
- Market Cap
- DNLI 1.8B
- ADUS 2.0B
- IPO Year
- DNLI 2017
- ADUS 2009
- Fundamental
- Price
- DNLI $12.74
- ADUS $101.25
- Analyst Decision
- DNLI Strong Buy
- ADUS Buy
- Analyst Count
- DNLI 16
- ADUS 11
- Target Price
- DNLI $37.57
- ADUS $134.73
- AVG Volume (30 Days)
- DNLI 1.7M
- ADUS 269.1K
- Earning Date
- DNLI 05-06-2025
- ADUS 05-05-2025
- Dividend Yield
- DNLI N/A
- ADUS N/A
- EPS Growth
- DNLI N/A
- ADUS 10.44
- EPS
- DNLI N/A
- ADUS 4.23
- Revenue
- DNLI N/A
- ADUS $1,154,599,000.00
- Revenue This Year
- DNLI N/A
- ADUS $24.63
- Revenue Next Year
- DNLI $372.05
- ADUS $5.91
- P/E Ratio
- DNLI N/A
- ADUS $23.94
- Revenue Growth
- DNLI N/A
- ADUS 9.06
- 52 Week Low
- DNLI $10.57
- ADUS $87.88
- 52 Week High
- DNLI $33.33
- ADUS $136.72
- Technical
- Relative Strength Index (RSI)
- DNLI 42.15
- ADUS 54.25
- Support Level
- DNLI $12.37
- ADUS $98.29
- Resistance Level
- DNLI $13.63
- ADUS $103.10
- Average True Range (ATR)
- DNLI 1.24
- ADUS 3.92
- MACD
- DNLI 0.23
- ADUS 0.71
- Stochastic Oscillator
- DNLI 50.94
- ADUS 77.55
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.